Skip to content
Screener

Amneal Pharmaceuticals, Inc. AMRX Specialty — Facilities costs

Similar metrics at other companies

Weave Communications logo
WEAVReportable Segment — Facilities costs
$2.33M+3.6%
Acadia Healthcare logo
ACHCSpecialty Treatment Facilities — Revenue
$133.52M-8.4%
Fox Factory Holding Corp. logo
FOXFSpecialty Sports Group — Number of distribution facilities
11-15.4%
EnerSys logo
ENSSpecialty — Other restructuring costs
$182K+1,755%
CNA Financial logo
CNASpecialty — Deferred acquisition costs
$454M+2.9%
Akamai Technologies logo
AKAMReportable Segment — Facilities-related costs
$22.91M+7.7%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.77B+129%
Enterprise value$8.21B+77.4%
P/E36.7×-711×
P/S1.9×+1.0×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept amrx:FacilitiesCosts.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001723128-26-000031
Line itemThree Months Ended June 30, 2026 / Affordable MedicinesThree Months Ended June 30, 2026 / SpecialtyThree Months Ended June 30, 2025 / Affordable MedicinesThree Months Ended June 30, 2025 / Specialty
Employee compensation and benefits$12,016$1,326$14,693$1,279
Materials and supplies8,7961,0228,108450
Product development and studies (1)(89)2,6157562,371
In-licensing and upfront milestones3,5006,350
Facilities costs1,479301,793735
Regulatory fees1,3342,932
Other (2)5,9871,0017,2671,230
Total$33,023$5,994$41,899$6,065

Item 1. Financial Statements (Unaudited)

FAQ

What is Amneal Pharmaceuticals, Inc.'s specialty — facilities costs?
Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — facilities costs of $30K in Q2 2026.
How has Amneal Pharmaceuticals, Inc.'s specialty — facilities costs changed year-over-year?
Amneal Pharmaceuticals, Inc.'s specialty — facilities costs decreased by 95.9% year-over-year, from $735K to $30K.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — facilities costs?
Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — facilities costs has grown at a -19.0% compound annual growth rate (CAGR), from $3.68M to $1.96M.
What does specialty — facilities costs mean?
Represents the direct expenses incurred for maintaining, leasing, and operating physical infrastructure dedicated to a specific business segment. Monitoring these costs helps assess the overhead efficiency and the scalability of the segment's operational footprint.

Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — facilities costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude